# To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944

> **NCT01934205** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 22 (actual)

## Conditions studied

- Infections, Bacterial

## Interventions

- **DRUG:** GSK2140944 (Single dose)
- **DRUG:** GSK2140944 (Multiple dose)

## Key facts

- **NCT ID:** NCT01934205
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-25
- **Primary completion:** 2013-12-21
- **Final completion:** 2013-12-21
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2017-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01934205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01934205, "To Evaluate Plasma and Pulmonary Pharmacokinetics of GSK2140944". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01934205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*